Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Jörn Krätzschmar

Jörn Krätzschmar publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Cell Adhesion Molecules Research, Retinal Diseases and Treatments and Pulmonary Hypertension Research and Treatments.

OpenAlex
World rank
#549,097
of 7,710,434 ranked researchers
Rank in Germany
#27,053
of 364,343
Works
56
Citations
3.5k
Citations per work
62.4
h-index
28
i10-index 36Top 17% in Molecular Biology
Jörn Krätzschmar

What does Jörn Krätzschmar research?

Jörn Krätzschmar's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (20%), Immunology and Microbiology (7%).

Everything else: 25 works · 45.3% of their workLife Sciences: 20 works · 35.0% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 28.4% of their workMolecular Biology: 13 works · 22.6% of their workGenetics: 3 works · 5.8% of their workImmunology and Microbiology: 4 works · 6.6% of their workImmunology: 4 works · 6.6% of their workHealth Sciences: 11 works · 19.7% of their workMedicine: 11 works · 19.7% of their workOncology: 4 works · 7.3% of their workOphthalmology: 4 works · 6.6% of their workPulmonary and Respiratory Medicine: 3 works · 5.8% of their workTHEIR WORKJörn Krätzschmar56works
Life Sciences35%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2545.3%
    1. Biochemistry, Genetics and Molecular Biology1628.4%
    2. Immunology and Microbiology46.6%
    1. Medicine1119.7%
  1. 1Molecular Biology23% of their works
  2. 2Oncology7% of their works
  3. 3Immunology7% of their works
  4. 4Ophthalmology7% of their works
  5. 5Genetics6% of their works
  6. 6Pulmonary and Respiratory Medicine6% of their works

Research topics

Which keywords describe Jörn Krätzschmar's research?

The keywords of their largest research topics: Inflammation, Angiogenesis, Extracellular Matrix, Vascular Endothelial Growth Factor, Cancer Progression, Cell Adhesion, Integrins and Macular Degeneration.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Inflammation112 topics
  2. Angiogenesis102 topics
  3. Extracellular Matrix102 topics
  4. Vascular Endothelial Growth Factor92 topics
  5. Cancer Progression82 topics
  6. Cell Adhesion61 topic
  7. Integrins61 topic
  8. Macular Degeneration51 topic
  9. Pulmonary Hypertension51 topic
  10. Retinal Pigment Epithelium51 topic
  11. Right Heart Assessment51 topic
  12. Calcineurin41 topic
  13. Cetuximab41 topic
  14. KRAS Mutations41 topic
  15. Matrix Metalloproteinases41 topic
  16. NFAT41 topic
  17. Tissue Inhibitors of Metalloproteinases41 topic
  18. VEGF41 topic
  19. endothelial progenitor cells41 topic
  20. Envenoming31 topic
  21. Snake Venom31 topic

Where does Jörn Krätzschmar work?

Jörn Krätzschmar's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Jörn Krätzschmar have?

OpenAlex counts 56 works and 3,494 citations for Jörn Krätzschmar, an h-index of 28, ranking #549,097 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jörn Krätzschmar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.